Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Stockholders' Equity (Unaudited)

v3.8.0.1
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Treasury Shares
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Cumulative effect of adoption of ASU 2016-09 $ 43,843   $ 6   $ 43,837  
Beginning Balance (in shares) at Dec. 31, 2016   86,062       4,975
Beginning Balance at Dec. 31, 2016 384,763 $ 86 534,348 $ (53) (119,260) $ (30,358)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Issuance of common stock (in shares)   982       98
Issuance of common stock 21,614 $ 1 21,613      
Issuance of restricted stock (in shares)   100       1,701
Issuance of restricted stock 0 $ 0 (2)     $ 2
Treasury stock purchase, at cost (in shares)           (838)
Treasury stock purchases, at cost (21,189)         $ (21,189)
Stock-based expense 35,919   35,919      
Interest rate swap agreements 102     102    
Foreign currency translation 86     86    
Reclassification of realized gain on cash flow hedge to earnings, net of tax (30)     (30)    
Equity component of convertible notes, net of issuance costs and deferred tax 61,390   61,390      
Purchases of convertible note hedges (62,549)   (62,549)      
Issuance of warrants 31,499   31,499      
Net income 21,242          
Ending Balance (in shares) at Sep. 30, 2017   87,144       4,014
Ending Balance at Sep. 30, 2017 $ 516,690 $ 87 $ 622,224 $ 105 $ (54,181) $ (51,545)